CN Patent

CN101641100A — 用于治疗、降低、改善或预防由抗细菌药物抗性的细菌引起的感染的氟喹诺酮类

Assigned to Bausch and Lomb Inc · Expires 2010-02-03 · 16y expired

What this patent protects

本发明涉及用于治疗、降低、改善或预防由某些对抗细菌药物具有抗性的细菌引起的感染的包含具有式I－VIII的氟喹诺酮的组合物。还涉及使用这样的组合物治疗、降低、改善或预防这样的感染的方法。

USPTO Abstract

本发明涉及用于治疗、降低、改善或预防由某些对抗细菌药物具有抗性的细菌引起的感染的包含具有式I－VIII的氟喹诺酮的组合物。还涉及使用这样的组合物治疗、降低、改善或预防这样的感染的方法。

Drugs covered by this patent

besifloxacin-hydrochloride (BESIFLOXACIN HYDROCHLORIDE)

Patent Metadata

Patent number: CN101641100A
Jurisdiction: CN
Classification: —
Expires: 2010-02-03
Drug substance claim: No
Drug product claim: No
Assignee: Bausch and Lomb Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.